In view of the importance of chiral amines as building blocks for biologically active pharmaceutical drugs, considerable effort has been devoted to the development of asymmetric catalytic methods for their preparation. Notable advances have been made by using transition-metal catalysis,[1a] organocatalysis,[1b] and artificial transfer hydrogenases.[1c] However, biocatalytic approaches have emerged as being especially ...
